Conexeu says CXU preclinical program completes 12-month P..O.F. phase, meets objectives
argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the Movement
Tvardi Therapeutics Announces Second Quarter 2026 Results and Provides Business Update
IDXX: Innovation and sector tailwinds support double-digit recurring revenue growth and expanding margins
Achieve Life Sciences Stock Has Nearly Tripled in the Last Year. Now It Just Needs to Turn a Profit.
BlackRock Health Sciences Term Trust files Form 3 for Chief Compliance Officer Charles Park